Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-4280

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70518-4280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Venlafaxine HCI Extended-Release 75 mg capsules. The capsules come in a quantity of 30. The prescription medication is for adults only and the source NDC is 31722-0003-20. It is manufactured by Camber Pharma, Inc. in Piscataway, NJ 08854. The medication should be kept out of reach of children and stored at 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F). Further usage directions can be found in the package insert.*

FDA Label Image

Figure-1 (Figure 1)

This text is a list of different conditions and factors related to the metabolism and effects of a medication called Venlafaxine in special populations like those with hepatic impairment, renal impairment, different genotypes, age, and gender. It also mentions PK parameters and fold change with 90% CI. The information likely serves as a guide for healthcare professionals when prescribing Venlafaxine to patients with these specific characteristics.*

FDA Label Image

Figure-2 (Figure 2)

This text provides information on the interacting drug Cimetidine and its effects on the analyte Imipramine. It includes details on fold change and 90% confidence intervals, along with data showing changes relative to the reference value. The text also mentions Voniataxine and Veniataxine as part of the interaction.*

FDA Label Image

Figure-3 (Figure 3)

This is a list of interacting drugs and analytes, along with pharmacokinetic parameters such as Cmax and AUC, as well as fold change and 90% confidence interval data. The drugs listed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The analytes include various metabolites and active moieties of these drugs. The data presented may be useful for studying drug interactions and their effects on pharmacokinetics.*

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.